An interventional study of accurate carb counting and Simplified qualitative meal size estimation in Type 1 Diabetes Mellitus, sponsored by Rabin Medical Center. Recruiting at 1 site in Israel. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-05-20.
Sponsored by Rabin Medical Center · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Diabetes Mellitus, Type 1 by Rabin Medical Center — 8 open to participants now, 8 under way, none of them phase 3. Diabetes Mellitus, Type 1 · Rabin Medical Center.
Among the 42 studies in Diabetes Mellitus, Type 1 by Rabin Medical Center, this one is the 4th largest by planned enrollment of the 38 interventional ones that give a count, is one of 3 that started in 2024, is one of 31 with no phase, and was the 39th registered.
3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.
Browse Diabetes Mellitus, Type 1 studies →8 of the 42 studies in Diabetes Mellitus, Type 1 by Rabin Medical Center are open now, in 2 countries. Recruiting first, the newest first:
Rabin Medical Center · Sites in Israel, Slovenia
Ages 6–75
Rabin Medical Center · Sites in Israel
Ages 2–45 · Healthy volunteers
Rabin Medical Center · Sites in Israel
Ages 18–35
Rabin Medical Center · Sites in Israel
Ages 2–45 · Healthy volunteers
Rabin Medical Center · Sites in Israel
Ages 9 mo–5 yrs
By country, each count listing its studies:
Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.
This study: 6 Years to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is above the median of 40 across 2,824 interventional studies indexed under Diabetes Mellitus, Type 1.
Median enrollment 30 across the 38 interventional studies, 10,150 across the 4 observational. Of the 31 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Rabin Medical Center is the lead sponsor of 393 studies on the registry; 30 are open to participants now.
2 of the studies in Diabetes Mellitus, Type 1 by Rabin Medical Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04834518Rabin Medical CenterScreening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus | 2027-03-31 |
| NCT06687434Rabin Medical CenterCarb Counting vs. Simplified Qualitative Meal-Size Estimation | 2027-11-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 42 studies in Diabetes Mellitus, Type 1 by Rabin Medical Center, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this study is to compare qualitative meal-size estimation to accurate carb counting in adolescents with Type One Diabetes using all available AID (Automated Insulin Delivery) systems. We will compare glucose control parameters and patient related outcome measures between the groups. 120 children and adolescents with type 1 Diabetes who begin using AID system will be randomly assigned to one of two groups: simplified qualitative meal size estimation or accurate carb counting. The study will last 6 months, with an additional optional follow up points at 12 and 24 months.
In the first visit all patients will receive nutrition guidance from the dietitian. In the accurate carb counting group, participants will use precise carb counting to manage their meals. In the simplified qualitative meal-size estimation group, participants will use a simplified meal announcement based on three presets for each meal, small, medium, or large, which will be personalized based on the dietitian's assessment. During the study, the dietitian will evaluate the insulin-to-carb ratio and meal estimation at least once in the first two weeks.
Follow-up visits will be scheduled at 4-6 weeks, 3, and 6 months after the study's initiation. At each visit participants will upload their data from their AID systems. Evaluation of their diabetes control will be made and an assessment regarding the carbohydrates calculation method. Digital questionnaires assessing diabetes distress, disordered eating behaviors, dietary regimen, and eating patterns will be provided at the beginning of the study and after 6 months, with an additional optional follow-up points that will be held at 12 and 24 months after the study's initiation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will use precise carb counting to manage their meals
Behavioral: accurate carb counting
Participants will use a simplified meal announcement based on three presets for each meal, small, medium, or large, which will be personalized based on the dietitian assessment.
Behavioral: Simplified qualitative meal size estimation
Participants will use precise carb counting to manage their meals
participants will use a simplified meal announcement based on three presets for each meal, small, medium, or large, which will be personalized based on the dietitian's assessment.
Percentage of time in target range (70-18mg/dl)
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Hemoglobin A1C
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Percentage Continuous glucose monitoting usage
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Number of Episodes of severe hypoglycemia
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Number of episodes of Diabetic Ketoacidosis
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Total daily insulin dose
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
basal insulin dose
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Number of manual boluses per day
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Number of announced meals per day
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Daily carbohydrates input
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Percentage of automated insulin delivery use
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Number of automated insulin delivery exits per week
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Percentage of automated boluses
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Score of Diabetes distress according to questionnaire
Time frame: At screening and after 6 months
Score of Disordered eating behaviors according to quesiotnnaire
Time frame: At screening and after 6 months
Score of Dietary regimen according to questionnaire
Time frame: At screening and after 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Dec 2024 (actual). Primary completion is estimated for Nov 2027, 34 months after the start.
Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 34 months is above that.
Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.